Savara Inc. Stock Prediction
AI-powered sentiment analysis and prediction trends for SVRA, updated each market day.
SVRA AI Sentiment
AI sees no strong directional signal for Savara Inc. stock over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
Sector
Exchange
Market Cap
$1,201,339,519
Cap Tier
Employees
70
Headquarters
AUSTIN, TX
Listed Since
Nov. 18, 1996
Website
SVRA Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
SVRA Volatility
Savara Inc. has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
